GlassScriptPhysician profile
Alap Upendra Patel
NPI 1639707086
$8,718.35
in general payments reported to CMS, 2019-2025
17 companies · $807 in 2025
The $807 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $403 · 2022: $1,126 · 2023: $1,984 · 2024: $4,400 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,835 · Food and Beverage: $2,756 · Education: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,835.05 |
| Food and Beverage | $2,755.95 |
| Education | $598.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,962.50 | 2023-2025 | |
| Medical Device Business Services, INC. | $948.97 | 2022-2024 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Memorygel Breast Implant |
| Tela Bio, INC. | $677.08 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $510.63 | 2022 | |
| Integra Lifesciences Corporation | $282.91 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mentor Worldwide LLC | $235.08 | 2021 | |
| Davol INC. | $229.87 | 2023-2024 | Phasix Mesh |
| Kci USA, INC. | $165.22 | 2022-2023 | Prevena |
| Aroa Biosurgery Incorporated | $144.32 | 2024 | |
| Kerecis Limited | $107.34 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Depuy Synthes Sales INC. | $103.75 | 2022 | |
| Mimedx Group, INC. | $97.85 | 2024-2025 | |
| Access Pro Medical, LLC | $92.15 | 2025 | Matriderm |
| Ethicon US, LLC | $66.84 | 2025 | Dermabond Prineo, Stratafix |
| Sanara Medtech INC. | $42.84 | 2024 | Celleraterx |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $29.68 | 2025 | |
| Smith+Nephew, INC. | $21.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alap Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.